Abstract Submission

Deadline for Abstract Submission : by August 31, 2020
Extended: by September 6, 2020

The abstracts submitted by March 31, 2020 will remain valid and be automatically transferred to the online conference.

Presentation Type

• E-Poster Presentation
• International Session (Oral): Presented in English
• Oral Presentation: Presented in Korean
• Outstanding Abstract Session:
  - Selected original articles that is not presented in int'l conferences; Presented in English

Selected presentations who demonstrate the highest levels of scientific and clinical impact will be recognized by scientific committee. In this session, original articles that is not presented in international conferences are required and will be presented in English.

  - Prize money will be awarded to each presenters of Outstanding Abstract Session.

Abstract Submission Rule

1) Deadline for Abstract Submission: by September 6, 2020
2) All abstracts must be written in English and submitted through the Meeting website.
3) Select your preferred type for your presentation. The Scientific Committee, however, reserves the right to make
    the final decision on the mode of presentation.
4) Submission of an abstract implies that the presenting author has the consent of all authors and has obtained
    necessary institutional clearances.
5) Submission of an abstract acknowledges acceptance for the abstract to be published in the official Meeting
    abstract book.
6) The presenting author must register at the time of acceptance of his or her abstract.
7) Previously published abstracts in cancer-related meetings can be also submitted as well as new unpublished
8) The Scientific Committee will review all submitted abstracts. The reviewing process is confidential and decisions
    are final.

Abstract Format

1) Title: Capitalize the first letter of the sentence only.
2) Authors: Names and surnames for each author must be provided. Do not include degrees or titles. Presenting
   author's name will be underlined. Corresponding author's name will be marked by asterisk (*) following the
3) Affiliations: Each author should be listed by department, institution, city and country.
4) Body of Abstract :
A. Original Articles
  • • Word Limit: 250 words
  • • The abstract body of original articles should be structured chronologically into 4 sections
  • • 1) Purpose - 2) Methods - 3) Results - 4) Conclusions
B. Case Report
  • • Word Limit: 150 words
  • • Case Reports are not encouraged and are considered only if justified by their unique significance or depth
        of studies on the case.
  • • The abstract should be unstructured and its length should not exceed 150 words.
5) Keywords: up to 3 keywords

Notification of Acceptance

Abstract Acceptance: Early October, 2020
All submitted abstracts will be reviewed by the Scientific Committee according to standard review procedures. Notification of acceptance will be sent by e-mail to presenting (submitting) and corresponding authors. If your abstract is accepted, please be sure to register no later than October 12, 2020. If you register late, your abstract may not be included in the meeting Abstract Book.

Withdrawal of Abstract

If the presenting author of an accepted abstract wishes to withdraw his or her abstract, please notify the secretariat. Also, if the presenting author does not register by October 12, 2020, the abstract will be automatically considered being withdrawn and excluded from the final program.

For any questions related to abstract submission, please contact the KCA secretariat.

Korean Cancer Association
Tel: +82-70-8850-0312/4459, E-mail: (scientific) cancer2@kams.or.kr